Morice William G, Katzmann Jerry A, Pittelkow Mark R, el-Azhary Rokea A, Gibson Lawrence E, Hanson Curtis A
Division of Hematopathology, Mayo Clinic, Rochester, MN 55905, USA.
Am J Clin Pathol. 2006 Mar;125(3):364-74.
The strengths and weaknesses of various laboratory methods for peripheral blood (PB) Sézary cell quantitation have not been compared rigorously. In this study, manual Sézary cell counting, qualitative and quantitative flow cytometry, T-cell receptor (TCR) Vbeta flow cytometry, and TCR polymerase chain reaction were performed on PB specimens from 11 patients with Sézary syndrome (SS), 9 with reactive erythroderma, 6 with mycosis fungoides, and 11 healthy control subjects. These methods identified neoplastic cells in more than 90% of SS cases. The diagnostic specificities of these tests varied; they were enhanced by applying criteria proposed by the International Society for Cutaneous Lymphoma. Comparison of sequentially analyzed specimens from 6 patients with SS revealed that although the absolute number of clonal cells was reduced, in some cases, these cells still constituted the vast majority of the CD4+ T-cell subset, suggesting that quantitative subset analysis might be sufficient to monitor changes in the PB tumor burden.
各种用于外周血(PB)塞扎里细胞定量的实验室方法的优缺点尚未得到严格比较。在本研究中,对11例塞扎里综合征(SS)患者、9例反应性红皮病患者、6例蕈样肉芽肿患者和11名健康对照者的PB标本进行了手动塞扎里细胞计数、定性和定量流式细胞术、T细胞受体(TCR)Vβ流式细胞术以及TCR聚合酶链反应。这些方法在90%以上的SS病例中识别出了肿瘤细胞。这些检测的诊断特异性各不相同;应用皮肤淋巴瘤国际协会提出的标准可提高其特异性。对6例SS患者的连续分析标本进行比较发现,尽管克隆细胞的绝对数量减少,但在某些情况下,这些细胞仍占CD4+T细胞亚群的绝大多数,这表明定量亚群分析可能足以监测PB肿瘤负荷的变化。